Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Croton cajucara
Arbre aromatique de l'Amazonie brésilienne utilisé extensivement dans la médecine traditionnelle amazonienne pour les affections hépatiques et métaboliques.
Croton cajucara is an aromatic tree from the Brazilian Amazon traditionally used for liver and metabolic conditions. Modern research suggests hepatoprotective, hypoglycemic, anti-inflammatory, and cholesterol-lowering properties, attributed to active compounds such as trans-dehydrocrotonin, terpenes, flavonoids, and alkaloids. However, clinical evidence remains limited (Grade C), and caution is warranted due to potential hepatotoxicity at high doses.
The hepatoprotective effects are primarily linked to trans-dehydrocrotonin, which modulates phase I and II detoxification enzymes (e.g., CYP450, glutathione S-transferase) and reduces oxidative stress via Nrf2 pathway activation. Blood sugar regulation may involve enhanced insulin sensitivity and inhibition of α-glucosidase, while anti-inflammatory actions are mediated through suppression of NF-κB and COX-2. Cholesterol lowering is thought to occur via upregulation of LDL receptor expression and inhibition of HMG-CoA reductase.
Arbre aromatique de l'Amazonie brésilienne utilisé extensivement dans la médecine traditionnelle amazonienne pour les affections hépatiques et métaboliques.
Croton cajucara is an aromatic tree from the Brazilian Amazon traditionally used for liver and metabolic conditions. Modern research suggests hepatoprotective, hypoglycemic, anti-inflammatory, and cholesterol-lowering properties, attributed to active compounds such as trans-dehydrocrotonin, terpenes, flavonoids, and alkaloids. However, clinical evidence remains limited (Grade C), and caution is warranted due to potential hepatotoxicity at high doses.
The hepatoprotective effects are primarily linked to trans-dehydrocrotonin, which modulates phase I and II detoxification enzymes (e.g., CYP450, glutathione S-transferase) and reduces oxidative stress via Nrf2 pathway activation. Blood sugar regulation may involve enhanced insulin sensitivity and inhibition of α-glucosidase, while anti-inflammatory actions are mediated through suppression of NF-κB and COX-2. Cholesterol lowering is thought to occur via upregulation of LDL receptor expression and inhibition of HMG-CoA reductase.